Clinical trial
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
NCT02314156
Study timeline
Study start (actual)2015-10-01Date precision: month
Registry last updated2023-02-22
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
BRCA1 Mutation Carrierunresolved
BRCA2 Mutation Carrierunresolved
Ductal Breast Carcinoma In Situunresolved
Lobular Breast Carcinoma In Situunresolved
Stage 0 Breast Cancerunresolved
Stage IA Breast Cancerunresolved
Stage IB Breast Cancerunresolved
Stage IIA Breast Cancerunresolved
Stage IIB Breast Cancerunresolved
Interventions
Sponsors & collaborators
Northwestern Universitylead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02314156 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.